A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension
Seedat, Y.K.; Vawda, E.I.; Mitha, S.; Ramasar, R.
South African Medical Journal 44(10): 300-301
1970
ISSN/ISBN: 0256-9574 PMID: 5443298 Document Number: 25321
Document emailed within 1 workday
Related Documents
Plouin, P.F.; Bréart, G.; Maillard, F.; Papiernik, E.; Relier, J.P. 1987: Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial Archives des Maladies du Coeur et des Vaisseaux 80(6): 952-955Pörsti, P. 1976: A comparison of debrisoquine and methyldopa in hypertension Annals of Clinical Research 8(1): 55-62
Greenberg, S. 1981: Effect of chronic administration of clonidine, propranolol and alpha-methyldopa on extensibility and biochemical properties of the veins in renal and spontaneous hypertension Journal of Pharmacology and Experimental Therapeutics 218(3): 779-790
Whelton, P.K.; Russell, R.P.; Sova-Schulz, K.; Wyndham, R.; Walker, W.G. 1979: Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial Journal of Cardiovascular Pharmacology 1(6 Suppl): S28-S37
Kho, T.L.; Schalekamp, M.A.; Zaal, G.A.; Wester, A.; Birkenhäger, W.H. 1975: Comparison between the effects of ST 600 and catapres Archives Internationales de Pharmacodynamie et de Therapie 214(2): 347-350
Clineschmidt, B.V.; Flataker, L.M.; Faison, E.P.; Haubrich, D.R. 1980: Alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors Archives Internationales de Pharmacodynamie et de Therapie 244(2): 231-243
Dunn, M.I.; Freeman, J. 1975: Moderate hypertension: treatment with guanethidine and methyldopa Current Therapeutic Research 18(2): 285-294
Beretta, R.; Cassi, E.; Colombo, A.; De Paoli, A.; Marciandi, C.; Renzetti, G.A. 1982: Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic La Clinica Terapeutica 103(5): 487-500
Sweet, R.D.; Lee, J.E.; McDowell, F. 1971: Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease Transactions of the American Neurological Association 96: 59-65
Caldwell, J.R.; Metts, J.C. 1981: Long-term treatment of hypertension with methyldopa. III. Tolerability Journal of Cardiovascular Pharmacology 3(Suppl 2): S92-S98
Bolzano, K.; Krempler, F.; Sandhofer, F. 1984: A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension Acta Medica Austriaca 11(2): 49-53
Zicot, M. 1980: Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine Revue Medicale de Liege 35(19): 652-654
Glasgow, G.L.; Henley, J.W.; Willoughby, E.W. 1974: L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease Australian and New Zealand Journal of Medicine 4(4): 373-378
Itskovitz, H.D.; Menduke, H. 1981: Long-term treatment of hypertension with methyldopa. I. Study objectives and design Journal of Cardiovascular Pharmacology 3(Suppl 2): S79-S84
Farsang, C. 1986: Update on alpha-methyldopa Therapia Hungarica 34(3): 139-149
Taylor, P.; Gillman, P.K.; Gaind, R. 1978: Alpha-methyldopa in schizophrenia Journal of Clinical Psychiatry 39(11): 815-816
Kaplinsky, N.; Fraenkel, O. 1972: Hemolytic anemia due to alpha-methyldopa Harefuah 83(11): 487-488
Koller, O.; Lehoczky, D. 1976: Immune hemolysis in the course of alpha methyldopa therapy Orvosi Hetilap 117(9): 545-546
Uspenskiĭ, A.E.; Korobov, N.V. 1976: Facilitation of the effects of L-DOPA by alpha-methyldopa Biulleten' Eksperimental'noi Biologii i Meditsiny 81(3): 314-316
Agarwal, R.K.; Bhatnagar, M.K.; Shukla, S.K.; Gupta, R.; Dwivedi, R.N. 1980: Methyldopa and propranolol in moderate hypertension Indian Heart Journal 32(1): 13-15